Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
10.1007/s11095-006-9032-3
Crossref journal-article
Springer Science and Business Media LLC
Pharmaceutical Research (297)
Bibliography

McNamara, D. P., Childs, S. L., Giordano, J., Iarriccio, A., Cassidy, J., Shet, M. S., Mannion, R., O’Donnell, E., & Park, A. (2006). Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API. Pharmaceutical Research, 23(8), 1888–1897.

Authors 9
  1. Daniel P. McNamara (first)
  2. Scott L. Childs (additional)
  3. Jennifer Giordano (additional)
  4. Anthony Iarriccio (additional)
  5. James Cassidy (additional)
  6. Manjunath S. Shet (additional)
  7. Richard Mannion (additional)
  8. Ed O'Donnell (additional)
  9. Aeri Park (additional)
References 33 Referenced 605
  1. G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–419 (1995). (10.1023/A:1016212804288) / Pharm. Res. by G. L. Amidon (1995)
  2. Calculated using Advanced Chemistry Development (ACD/Labs) Software Solaris V4.67 (1994–2005 ACD/Labs).
  3. M. Yazdanian, S. L. Glynn, J. L. Wright, and A. Hawi. Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm. Res. 15(9):1490–1494 (1998). (10.1023/A:1011930411574) / Pharm. Res. by M. Yazdanian (1998)
  4. S. L. Childs, L. C. Chyall, J. T. Dunlap, V. N. Smolenskaya, B. C. Stahly, and G. P. Stahly. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoexetine hydrochloride with benzoic, succinic, and fumaric acids. J. Am. Chem. Soc. 126:13335–13342 (2004). (10.1021/ja048114o) / J. Am. Chem. Soc. by S. L. Childs (2004)
  5. J. F. Remenar, S. L. Morissette, M. L. Peterson, B. Moulton, J. M. MacPhee, H. R. Guzman, and O. Almarsson. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 125:8456–8457 (2003). (10.1021/ja035776p) / J. Am. Chem. Soc. by J. F. Remenar (2003)
  6. J. W. Bettis, J. L. Lach, and J. Hood. Effect of complexation with phenobarbital on biologic availability of theophylline from 3 tablet formulations. Am. J. Hosp. Pharm. 30(3):240–243 (1973). / Am. J. Hosp. Pharm. by J. W. Bettis (1973)
  7. J. Bernstein, M. C. Etter, and L. Leiserowitz. The role of hydrogen bonding in molecular assemblies. In H.-B. D. Buergi, and Jack D (eds.), Struct. Correl., VCH, Weinheim, Germany, 1994, pp. 431–507. (10.1002/9783527616091.ch11) / Struct. Correl. by J. Bernstein (1994)
  8. I. D. H. Oswald, D. R. Allan, P. A. McGregor, W. D. S. Motherwell, S. Parsons, and C. R. Pulham. The formation of paracetamol (acetaminophen) adducts with hydrogen-bond acceptors. Acta Crystallogr. Sect. B-Struct. Commun. 58:1057–1066 (2002). (10.1107/S0108768102015987) / Acta Crystallogr. Sect. B-Struct. Commun. by I. D. H. Oswald (2002)
  9. N. Sardone, G. Bettinetti, and M. Sorrenti. Trimethoprim-sulfadimidine 1:2 molecular complex monohydrate. Acta Crystallogr., C Cryst. Struct. Commun. 53:1295–1299 (1997). (10.1107/S0108270197000425) / Acta Crystallogr., Sect. C Cryst. Struct. Commun. by N. Sardone (1997)
  10. S. Nakao, S. Fujii, T. Sakaki, and K. I. Tomita. Crystal and molecular-structure of 2-1 molecular-complex of theophylline with phenobarbital. Acta Crystallogr. Sect. B-Struct. Commun. 33:1373–1378 (1977) (MAY13). (10.1107/S0567740877006116) / Acta Crystallogr. Sect. B-Struct. Commun. by S. Nakao (1977)
  11. M. R. Caira, T. G. Dekker, and W. Liebenberg. Structure of a 1:1 complex between the anthelmintic drug mebendazole and propionic acid. J. Chem. Crystallogr. 28(1):11–15 (1998). (10.1023/A:1021766300133) / J. Chem. Crystallogr. by M. R. Caira (1998)
  12. M. C. Etter, and G. M. Frankenbach. Hydrogen-bond directed cocrystallization as a tool for designing acentric organic solids. Chem. Mater. 1(1):10–12 (1989). (10.1021/cm00001a005) / Chem. Mater. by M. C. Etter (1989)
  13. C. B. Aakeroy. Crystal engineering: strategies and architectures. Acta Crystallogr. Sect. B-Struct. Commun. 53:569–586 (1997). (10.1107/S0108768197008446) / Acta Crystallogr. Sect. B-Struct. Commun. by C. B. Aakeroy (1997)
  14. M. C. Etter and D. A. Adsmond. The use of cocrystallization as a method of studying hydrogen-bond preferences of 2-aminopyrimidine. J. Chem. Soc., Chem. Commun. 8:589–591 (1990). (10.1039/c39900000589) / J. Chem. Soc., Chem. Commun. by M. C. Etter (1990)
  15. G. R. Desiraju. Supramolecular synthons in crystal engineering—a new organic-synthesis. Angew. Chem.-Int. Edit. Engl. 34(21):2311–2327 (1995). (10.1002/anie.199523111) / Angew. Chem.-Int. Edit. Engl. by G. R. Desiraju (1995)
  16. A. Nangia and G. R. Desiraju. Supramolecular structures—reason and imagination. Acta Crystallogr. Sect. A 54:934–944 (1998). (10.1107/S0108767398008551) / Acta Crystallogr. Sect. A by A. Nangia (1998)
  17. B. Rodriguez-Spong, C. P. Price, A. Jayasankar, A. J. Matzger, and N. Rodriguez-Hornedo. General principles of pharmaceutical solid polymorphism: a supramolecular perspective. Adv. Drug Deliv. Rev. 56(3):241–274 (2004). (10.1016/j.addr.2003.10.005) / Adv. Drug Deliv. Rev. by B. Rodriguez-Spong (2004)
  18. J. J. Kane, T. Nguyen, J. Xiao, F. W. Fowler, and J. W. Lauher. The host guest co-crystal approach to supramolecular structure. Mol. Cryst. Liquid Cryst. 356:449–458 (2001). (10.1080/10587250108023723) / Mol. Cryst. Liquid Cryst. by J. J. Kane (2001)
  19. P. Vishweshwar, A. Nangia, and V. M. Lynch. Molecular complexes of homologous alkanedicarboxylic acids with isonicotinamide: X-ray crystal structures, hydrogen bond synthons, and melting point alternation. Cryst. Growth Des. 3(5):783–790 (2003). (10.1021/cg034037h) / Cryst. Growth Des. by P. Vishweshwar (2003)
  20. P. Vishweshwar, A. Nangia, and V. M. Lynch. Supramolecular synthons in phenol-isonicotinamide adducts. Crystengcomm.: 164–168 (2003). (10.1039/B304078J)
  21. M. C. Etter. Aggregate structures of carboxylic acids and amides. Isr. J. Chem. 25(3–4):312–319 (1985). (10.1002/ijch.198500051) / Isr. J. Chem. by M. C. Etter (1985)
  22. SMART Version 5.55, 2000, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison Wisconsin 53711–5373.
  23. SAINT Version 6.02, 1999, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison Wisconsin 53711–5373.
  24. SHELXTL V5.10, 1997, Bruker AXS, Inc., Analytical X-ray Systems, 5465 East Cheryl Parkway, Madison Wisconsin 53711–5373.
  25. A. J. C. Wilson (ed.), International Tables for X-ray Crystallography, Volume C. Kynoch, Academic, Dordrecht, 1992, Tables 6.1.1.4 (pp. 500–502) and 4.2.6.8 (pp. 219–222).
  26. C. G. S. Wermuth. P. H. Handbook of Pharmaceutical Salts; Properties, Selection, and Use (P. H. W. Stahl, C. G., ed.). Verlag Helvitica Chimica Acta, Zurich and Wiley-VCH: Weinheim, 306 (2002).
  27. W. C. McCrone, Jr., Fusion Methods in Chemical Microscopy. Interscience, New York, 1957. / Fusion Methods in Chemical Microscopy by W. C. McCrone Jr (1957)
  28. A. Kofler. Behavior of crystalline solid solution during melting and crystallization. Mikroskopie. 11(5–6):140–155 (1956). / Mikroskopie. by A. Kofler (1956)
  29. M. Kunhert-Brandstaetter. 40 Years of Kofler methods. Pharma Int. (Engl. Ed.) 5:5–11 (1971). / Pharma Int. (Engl. Ed.) by M. Kunhert-Brandstaetter (1971)
  30. R. N. Rai, and K. B. R. Varma. Phase diagram and dielectric studies of binary organic materials. Mater. Lett. 44(5):284–293 (2000). (10.1016/S0167-577X(00)00046-X) / Mater. Lett. by R. N. Rai (2000)
  31. U. S. Rai and S. George. Some thermochemical studies on binary faceted organic eutectics and 1:1 molecular complexes. J. Therm. Anal. 46(6):1809–1820 (1996). (10.1007/BF01980785) / J. Therm. Anal. by U. S. Rai (1996)
  32. N. R. Jagannathan and C. N. R. Rao. A 13C NMR spectroscopic study of the phase transitions of alkane dicarboxylic acids in the solid state. Chem. Phys. Lett. 140(1):46–50 (1987). (10.1016/0009-2614(87)80414-1) / Chem. Phys. Lett. by N. R. Jagannathan (1987)
  33. S. J. Nehm, B. Rodriguez-Spong, and N. Rodriguez-Hornedo. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst. Growth Des. 6(2):592–600 (2006). (10.1021/cg0503346) / Cryst. Growth Des. by S. J. Nehm (2006)
Dates
Type When
Created 19 years, 1 month ago (July 10, 2006, 4:56 p.m.)
Deposited 1 year, 7 months ago (Feb. 5, 2024, 2:21 a.m.)
Indexed 2 days, 8 hours ago (Sept. 4, 2025, 9:31 a.m.)
Issued 19 years, 1 month ago (July 11, 2006)
Published 19 years, 1 month ago (July 11, 2006)
Published Online 19 years, 1 month ago (July 11, 2006)
Published Print 19 years, 1 month ago (Aug. 1, 2006)
Funders 0

None

@article{McNamara_2006, title={Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API}, volume={23}, ISSN={1573-904X}, url={http://dx.doi.org/10.1007/s11095-006-9032-3}, DOI={10.1007/s11095-006-9032-3}, number={8}, journal={Pharmaceutical Research}, publisher={Springer Science and Business Media LLC}, author={McNamara, Daniel P. and Childs, Scott L. and Giordano, Jennifer and Iarriccio, Anthony and Cassidy, James and Shet, Manjunath S. and Mannion, Richard and O’Donnell, Ed and Park, Aeri}, year={2006}, month=jul, pages={1888–1897} }